Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully

Clinical trial NCT06774872 · RECRUITING

Trial details

NCT number: NCT06774872
Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2025-04-30
Primary completion: 2027-01-15
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.